StockScan > Holders > Baker Bros. Advisors

Baker Bros. Advisors's Portfolio and 13F Filing

Value: $7.25B
Website: www.bakerbrothers.com
CIK: 0001263508
Phone: 212-339-5690
Address: 860 Washington Street, New York, NY (10014)
Latest 13F Filing: 2021-02-17
Baker Bros. Advisors's Stock Holdings & 13F Form
# Stock Name Symbol Current Price

Previous Holdings

(# Shares)

Current Holdings

(# Shares)

 Current Value Percent
21 Protagonist Therapeutics, Inc. PTGX $25.61 1,911,446

1,436,192

up arrow -475,254

 		$36,780,877 0.51%
22 Alkermes plc - Ordinary Shares ALKS $23.85 1,244,744

1,535,149

up arrow 290,405

 		$36,613,304 0.51%
23 Xenon Pharmaceuticals Inc. XENE $39.88 799,102

687,386

up arrow -111,716

 		$27,412,954 0.38%
24 Global Blood Therapeutics, Inc. GBT $29.59 47,000

920,375

up arrow 873,375

 		$27,233,896 0.38%
25 Crinetics Pharmaceuticals, Inc. CRNX $42.97 317,857

616,520

up arrow 298,663

 		$26,491,864 0.37%
26 Nurix Therapeutics Inc NRIX $13.59 N/A 1,788,921 $24,311,436 0.34%
27 Amarin Corporation plc - Americ AMRN $0.86 34,496,685

27,991,761

up arrow -6,504,924

 		$24,053,320 0.33%
28 Viking Therapeutics, Inc. VKTX $63.42 425,000

363,980

up arrow -61,020

 		$23,083,612 0.32%
29 Cerus Corporation CERS $1.68 13,713,195

13,713,195

up arrow 0

 		$23,038,168 0.32%
30 Igm Biosciences Inc IGMS $7.20 3,144,223

3,144,892

up arrow 669

 		$22,643,222 0.31%
31 Assembly Biosciences, Inc. ASMB $13.41 1,541,618

1,541,418

up arrow -200

 		$20,670,415 0.29%
32 Ultragenyx Pharmaceutical Inc. RARE $42.37 N/A 444,444 $18,831,092 0.26%
33 Mereo Biopharma Group Plc MREO $2.64 N/A 6,030,293 $15,919,974 0.22%
34 Heron Therapeutics, Inc. HRTX $2.64 6,018,104

5,994,704

up arrow -23,400

 		$15,826,019 0.22%
35 Mirum Pharmaceuticals Inc MIRM $23.81 583,333

647,313

up arrow 63,980

 		$15,412,523 0.21%
36 Zymeworks Inc. ZYME $8.85 1,708,472

1,708,472

up arrow 0

 		$15,119,977 0.21%
37 Forma Therapeutics Holdings Inc FMTX $7.39 2,000,000

2,024,876

up arrow 24,876

 		$14,963,834 0.21%
38 Albireo Pharma, Inc. ALBO $31.04 369,047

412,466

up arrow 43,419

 		$12,802,945 0.18%
39 Abeona Therapeutics Inc. ABEO $7.57 N/A 1,590,686 $12,041,493 0.17%
40 ChemoCentryx, Inc. CCXI $15.64 945,221

656,710

up arrow -288,511

 		$10,270,944 0.14%
Related 13F Filings:
berkshire hathaway 13f,   sec 13f filing list,   warren buffett 13f,   baker brothers 13f,   fundsmith 13f ,   valueact 13f,   greenlight capital 13f,   dorsey asset management 13f,   ra capital 13f,   dragoneer 13f,   vanguard group inc 13f,   hillhouse 13f,   citadel 13f,   morgan stanley 13f,   spruce house 13f,   fmr llc 13f,   sachem head 13f,   duquesne capital 13f,   maverick capital 13f,   soros fund management 13f,   light street capital 13f,   bronte capital 13f,   corvex 13f,   adw capital 13f,   arlington value capital 13f,   greenhaven road capital 13f,   fisher investments 13f,   bares capital management 13f,   generation investment management 13f,   giverny capital 13f,   goldman sachs 13f,   omega advisors 13f,   thomson reuters 13f